CAMBRIDGE, Mass. (BUSINESS WIRE) ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced the appointment of Paul Perreault to its Board of Directors, effective December 5, 2023. Mr. Perreault most recently served as Chief Executive Officer of CSL and brings over 40 yea.
DUBLIN (BUSINESS WIRE) The "Plasma Fractionation Market by Type of Company, Scale of Operation, Type of Plasma-derived Therapeutic Products Manufactured, Therapeutic Areas of Plasma-derived Products and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035" report has been added to ResearchAndM.
/PRNewswire/ The "Plasma Fractionation Market by Type of Company, Scale of Operation, Type of Plasma-derived Therapeutic Products Manufactured, Therapeutic.
After making two audacious bets on overseas acquisitions, the least hyped privatisation of the 1990s now dominates a global biotech niche in plasma-based products.